Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted FDA research opportunity (U01 cooperative agreement) to identify and evaluate possible approaches to addressing nitrosamine impurities in drugs. Eligibility, funding amounts, a…
- Deadline
- Not specified
- Posted
- Nov 24, 2023
- Award amount
- Amount not specified
In plain English
This is a forecasted FDA research opportunity (U01 cooperative agreement) to identify and evaluate possible approaches to addressing nitrosamine impurities in drugs. Eligibility, funding amounts, and deadlines have not yet been published. U01 awards generally suit research institutions, universities, and similar organizations rather than individuals or general nonprofits. Review the full notice once released to confirm who may apply.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from Food and Drug Administration — soonest deadline first.
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration · Up to $250K · Due Jan 29, 2027
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration · Up to $600K · Due Feb 8, 2028
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration · Up to $1.3M · Due May 12, 2028
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration · Up to $900K · Due May 16, 2028
Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
Food and Drug Administration · Amount varies · No deadline listed
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration · Amount varies · No deadline listed
Also listed under Food and Drug Administration.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.